IVF HARTMANN Holding AG header image

IVF HARTMANN Holding AG

VBSN

Equity

ISIN CH0187624256 / Valor 18762425

SIX Swiss Exchange (2024-09-18)
CHF 137.00%

IVF HARTMANN Holding AG
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

IVF HARTMANN Holding AG, headquartered in Neuhausen am Rheinfall, Switzerland, is a subsidiary of the HARTMANN GROUP based in Heidenheim, Germany, and has been a prominent player in the Swiss medical consumables sector for over 150 years. With approximately 330 employees in Switzerland, the company focuses on developing and providing innovative medical products and services across various segments, including incontinence care, wound treatment, risk prevention in hospitals (notably in operating rooms), and first aid. These core areas are complemented by additional product segments such as cotton and therapeutic plasters, enhancing the company's medical expertise. IVF HARTMANN combines its products with customized services to meet the evolving needs of its clients, which range from individual practitioners and hospitals to nursing homes, pharmacies, drugstores, and the retail food industry. The company also offers targeted training and employs specialized consultants to support its clientele, further establishing its reputation for medical competence both domestically and internationally.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

24.5%1Y
-9.27%3Y
-13.3%5Y

Performance

27.7%1Y
32.5%3Y
31.9%5Y

Volatility

Market cap

390 M

Market cap (USD)

Daily traded volume (Shares)

188

Daily traded volume (Shares)

1 day high/low

137 / 136

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Dermapharm Holding SE
Dermapharm Holding SE Dermapharm Holding SE Valor: 40166352
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.43%EUR 35.10
Formycon AG
Formycon AG Formycon AG Valor: 12194189
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.10%EUR 49.35
Maternus-Kliniken AG
Maternus-Kliniken AG Maternus-Kliniken AG Valor: 335800
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.35%EUR 1.74
Vitrolife AB
Vitrolife AB Vitrolife AB Valor: 41707777
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.18%SEK 237.80
Elekta AB
Elekta AB Elekta AB Valor: 613625
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.88%SEK 68.70
BioArctic AB
BioArctic AB BioArctic AB Valor: 38514501
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.59%SEK 170.30
Camurus AB
Camurus AB Camurus AB Valor: 30510553
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.15%SEK 663.00
4basebio PLC
4basebio PLC 4basebio PLC Valor: 112829117
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%EUR 17.10
Cassava Sciences Inc
Cassava Sciences Inc Cassava Sciences Inc Valor: 46983284
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.13%USD 30.32
Stryker Corp
Stryker Corp Stryker Corp Valor: 974330
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.71%USD 361.36